top of page
News
MitoSense to Attend MHSRS, August 4 -7, 2025
MitoSense, Inc. is proud to announce its participation in the 2025 Military Health System Research Symposium (MHSRS), taking place August...
Jul 29
MitoSense's Collaboration with the VA and WRAIR Highlighted in House Hearing with HHS Secretary RFK, Jr.
Earlier this week, the U.S. House of Representatives Energy and Commerce Health Subcommittee held a hearing with Department of Health and...
Jun 26
MitoSense’s MOT™ Technology Featured In Newsmax Article Highlighting Secretary Kennedy’s Vision To Tackle Mitochondria Dysfunction To Fight Chronic Disease
MitoSense’s MOT™ technology was featured in a recent Newsmax article. The article highlights how U.S. Department of Health and Human...
Apr 29
MitoSense Secures Japanese Patent for Groundbreaking Mitochondria-Based Therapy for Neurodegenerative Diseases
February 4, 2025 – Plymouth, MA – MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, is...
Feb 3
bottom of page